Nian-Siou Wu

Mr. Nian-Siou Wu

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 June 2022 in Cellular Signalling
Verified
Journal Article
Closed access
NWNian-Siou Wu
Nian-Siou Wu
YLYi-Fan Lin
Yi-Fan Lin
IMI. Chu Ma
I. Chu Ma
KJKo Huey Jiun
Ko Huey Jiun
YHYi-Ren Hong
Yi-Ren Hong

4 August 2022 in Biomedicines
Verified
Journal Article
Open access
PDF file
WCWei-Chung Chen
Wei-Chung Chen
CWChun-Chieh Wu
Chun-Chieh Wu
Yi-Hsun ChenYi-Hsun Chen
Yi-Hsun Chen
JLJui-Ying Lee
Jui-Ying Lee
YWYao-Kuang Wang
Yao-Kuang Wang
IWI-Chen Wu
I-Chen Wu
Esophageal cancer has a dismal prognosis with a five-year survival rate below 20%. Recently, immunotherapy has become a new standard of care for this cancer; therefore, we aimed to examine the programmed death ligand 1 (PD-L1) expression in esophageal squamous cell carcinoma (ESCC) tissues before and after concurrent chemoradiation therapy (CCRT). In total, 64 patients with pre-CCRT ESCC specimens were examined for PD-L1 expression, with twenty-three of them having a partial response (N = 23) or stable disease (N = 1) after CCRT while post-CCRT tissue specimens were collected. All of them were tested for PD-L1 and 15 of them also had CD8 expression in the paired ESCC samples. The prevalence of PD-L1 positivity was 54.7% and we found a trend of decreased PD-L1 expression and increased CD8 positive signal after CCRT. High pre-CCRT PD-L1 H-score in tumors was related to poor prognosis (adjusted hazard ratio = 2.81; p = 0.02), although CD8 signal was not associated with overall survival either in pre- or post-CCRT treatment. In conclusion, we found that PD-L1 expression tended to decrease in CCRT responders and our result supports PD-L1 expression in tumor as a predictor of ESCC prognosis.

11 July 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
KJKo Huey Jiun
Ko Huey Jiun
CTCheng yu Tsai
Cheng yu Tsai
TNThi-Huong Nguyen
Thi-Huong Nguyen
TCTai-Shan Cheng
Tai-Shan Cheng
Chi-Ying F. HuangChi-Ying F. Huang
Chi-Ying F. Huang
YHYi-Ren Hong
Yi-Ren Hong
Drp1 is considered the master regulator of mitochondrial fission and affects the proper segregation during mitosis. Here, we identified two clusters on mitochondria, including Drp1-Ser-616/Mff/Mid51 and-Drp1-Ser637/Fis1/Mid49 for midzone fission (division) and peripheral fission signatures, respectively. This study revealed that phospho-Drp1-Ser637 is involved in mitigating mitochondrial oxidative stress, resolving a long-standing localization issue. Additionally, we demonstrated that Mid49 and Mid51 exhibit distinct functions in recruiting Drp1 for mitochondrial fission. It also confirmed the essential role of the Fis1 and Mid49 adaptors contributed into mitochondrial fission within the phospho-Drp1-Ser637/Fis1/Mid49 cluster during M-phase. Moreover, it suggested that there is mutual exclusivity between two clusters of phospho-Drp1 with four adaptors on mitochondria, as well as varied responses to specific anti-cancer drugs during mitotic arrest. Remarkably, the upregulation of the spindle assembly checkpoint (SAC) was also observed, ensuring the prolongation of M-phase with the formation of multipolar spindles. Collectively, the phospho-Drp1-637/Fis1/Mid49 cluster may not only function in peripheral fission (mitophagy) but also serve as a key SAC coordinator for the regulation of spindle assembly during mitotic arrest. These findings appear to be mutually exclusive of phospho-Drp1 with four adaptors on mitochondria and vary in response to specific anti-cancer drugs.